Natco Pharma to commence Rs 2.5-billion share buyback on November 19
The company has proposed to buy a minimum number of 1.25 million shares from the open market route in the six-month period
)
Explore Business Standard
The company has proposed to buy a minimum number of 1.25 million shares from the open market route in the six-month period
)
Natco Pharma Limited on Friday announced the share buyback schedule commencing on November 19. Last week, the company board decided to buy back shares for a price of Rs 1,000 per share from the open market by spending a maximum of Rs 2.5 billion.
While announcing the schedule, the company said the buyback of shares to an extent of at least 50 per cent of the amount earmarked for this purpose would be completed within six months from the scheduled buyback date. The price of shares determined for buyback comes at a premium of little over 40 per cent of the closing price of company shares on October 26, 2018.
The company has proposed to buy a minimum number of 1.25 million shares from the open market route in the six-month period.
The promoters and promoter group hold 48.25 per cent shares in the company, while 24.31 per cent equity shares are held by foreign institutional investors under the public shareholding classification.
Already subscribed? Log in
Subscribe to read the full story →
3 Months
₹300/Month
1 Year
₹225/Month
2 Years
₹162/Month
Renews automatically, cancel anytime
Over 30 premium stories daily, handpicked by our editors


News, Games, Cooking, Audio, Wirecutter & The Athletic
Digital replica of our daily newspaper — with options to read, save, and share


Insights on markets, finance, politics, tech, and more delivered to your inbox
In-depth market analysis & insights with access to The Smart Investor


Repository of articles and publications dating back to 1997
Uninterrupted reading experience with no advertisements


Access Business Standard across devices — mobile, tablet, or PC, via web or app
First Published: Nov 09 2018 | 4:41 PM IST